Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
Smarter benefits equal a stronger ROI. Individualized Flexible Benefits Plans are strategic investments in workforce ...
Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...
Staff at Clark Regional Medical Center in Winchester are grappling with uncertainty following recent announcements of ...
In recent years, Medica and Blue Cross of Minnesota provided millions in pay to their chief executives at the end of the road ...
Then ¥9000 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results